arrow
W

William D. Foulkes

mcgill university
H指数:125
被引数:6.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population

权衡益处、成本与危害:将癌症易感性检测从遗传诊所扩展至普通人群的政策启示

2026-09-250
PRE
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics

世界卫生组织遗传性肿瘤综合征分类:遗传学考虑

2026-06-160
OA
Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcoma

空间单细胞转录组分析揭示了DICER1综合征相关肉瘤的肿瘤发育层次结构

2026-03-300
OAAI
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium

遗传性癌症的非侵入性筛查: 一项随机对照试验,用于在CHARM联盟中测试基于游离DNA的早期检测

2026-01-290
OA
Assessing and predicting cutaneous leiomyoma severity in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study

评估和预测遗传性平滑肌瘤病和肾细胞癌综合征中皮肤平滑肌瘤的严重程度:一项观察性研究

2025-12-260
PRE
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2

更年期激素治疗和具有致病性变异的女性患乳腺癌的风险 <i>BRCA1</i> 或者 <i>BRCA2</i>

2025-12-170
PRE
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1

BRCA1致病性变异携带者中,根据突变类型和位置划分的乳腺癌风险

2025-12-150
OAAI
Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort

BRCA1或BRCA2致病性变异携带者中的子宫内膜异位症:一项大型多中心BRCA携带者队列的描述性分析

2025-12-010
OAAI
ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age

ASO视觉摘要:60岁后接受基因检测的老年BRCA1/2和PALB2携带者中风险降低性乳房切除术的接受情况

2025-11-100
PRE